Skip to content
FDA Approved Metabolic & Weight Loss

Secretin

also known as: SCT, Human secretin

The first hormone ever discovered — a 27-amino-acid gut peptide that stimulates pancreatic bicarbonate secretion and opened the entire field of endocrinology in 1902.

A 27-amino-acid peptide released by S-cells of the duodenum in response to gastric acid that stimulates pancreatic bicarbonate and bile secretion, inhibits gastrin, and is FDA-approved as a diagnostic agent for pancreatic function and gastrinoma.

Mechanism of action

Binds the secretin receptor (SCTR), a class B GPCR coupled to Gs/adenylyl cyclase/cAMP. In pancreatic duct cells, stimulates bicarbonate and water secretion. In the stomach, inhibits gastrin release. In the liver, stimulates bile flow.

Primary uses

  • Endogenous pancreatic bicarbonate secretion
  • Diagnostic: secretin stimulation test for gastrinoma
  • Diagnostic: pancreatic function testing
  • Historical significance: first hormone ever identified (1902)

Typical dosing

0.2-0.4 mcg/kg single diagnostic dose (IV)

Diagnostic use only: 0.2 mcg/kg IV for gastrinoma testing.

Regulatory status

Synthetic human secretin (SecreFlow/ChiRhoStim) is FDA-approved as a diagnostic agent for pancreatic exocrine function testing, gastrinoma localization, and facilitating MRCP imaging. First discovered by Bayliss and Starling in 1902 — the experiment that coined the word 'hormone.'

References

  1. [pubmed] Bayliss WM, Starling EH. "The mechanism of pancreatic secretion." J Physiol. 1902;28(5):325-353.
  2. [review] Afroze S, et al. "The physiological roles of secretin and its receptor." Ann Transl Med. 2013;1(3):29.

Related peptides

Disclaimer

This entry is for educational purposes only and does not constitute medical advice. Dosing information reflects published regulatory or research data and is not a recommendation. Many compounds described here are not approved for human use in the United States. Consult a licensed medical professional before considering any peptide therapy.